Chiron Investment Management’s Elevance Health ELV Stock Holding History

Chiron Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,121	Closed	-$8.38M	–	97
2024 Q3	$8.38M	Sell	16,121 -6,255	-28%	-$3.34M	2.95%	9
2024 Q2	$12.1M	Sell	22,376 -7,017	-24%	-$3.71M	4.76%	4
2024 Q1	$15.2M	Sell	29,393 -11,176	-28%	-$5.56M	6.61%	1
2023 Q4	$19.1M	Buy	40,569 +587	+1%	+$271K	7.29%	2
2023 Q3	$17.4M	Buy	39,982 +13,817	+53%	+$6.27M	7.35%	2
2023 Q2	$11.6M	Buy	+26,165	New	+$12.1M	3.26%	10
2023 Q1	–	Sell	-22,787	Closed	-$11.7M	–	144
2022 Q4	$11.7M	Buy	22,787 +10,894	+92%	+$5.53M	2.74%	15
2022 Q3	$5.4M	Buy	+11,893	New	+$5.69M	1.09%	32
2022 Q2	–	Sell	-46,273	Closed	-$22.7M	–	121
2022 Q1	$22.7M	Buy	46,273 +25,944	+128%	+$11.9M	2.61%	18
2021 Q4	$9.42M	Buy	+20,329	New	+$8.55M	1.03%	36

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Chiron Investment Management's ELV Position: Q4 2024 in Review

Chiron Investment Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 16,121 shares — an estimated $8.38M sold.

Chiron Investment Management first reported a position in ELV in Q4 2021 and held it in 10 quarters. The position peaked at $22.7M in Q1 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Chiron Investment Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Chiron Investment Management sold 16,121 Elevance Health shares in Q4 2024, an estimated $8.38M.
Chiron Investment Management first reported a position in Elevance Health in Q4 2021 and held it in 10 quarters.
Chiron Investment Management's Elevance Health position peaked at $22.7M in Q1 2022.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Chiron Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.